Benzinga | Mar 11, 2021 04:37PM EST

KemPharm FY EPS $(1.07) Misses $(0.64) Estimate, Sales $2.40M Beat $2.00M Estimate

KemPharm (NASDAQ:KMPH) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.64) by 67.19 percent. This is a 494.44 percent decrease over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $2.40 million which beat the analyst consensus estimate of $2.00 million by 20.00 percent. This is a 74.42 percent increase over sales of $1.38 million the same period last year.